Bradley Pharmaceuticals Founder and Senior Management Form Company Specializing in Dermatology and Podiatry Markets FAIRFIELD, N.J., May 13 /PRNewswire/ -- Medimetriks Pharmaceuticals, Inc...
NEW YORK, Feb. 21 /PRNewswire/ -- QED International Associates, Inc., administrator for the HealthShares(TM) Indexes, a series of 20 underlying indexes for the HealthShares(TM) Exchange-Traded...
NEW YORK, Feb. 14 /PRNewswire/ -- National Penn Bancshares Inc. (NASD: NPBC) will replace Bradley Pharmaceuticals Inc. (NYSE:BDY) in the S&P SmallCap 600 after the close of trading on Thursday...
FAIRFIELD, N.J., Jan. 17 /PRNewswire-FirstCall/ -- Bradley Pharmaceuticals, Inc. (NYSE:BDY) announced today that it has filed a definitive proxy statement with the Securities and Exchange...
FAIRFIELD, N.J., Dec. 14 /PRNewswire-FirstCall/ -- Bradley Pharmaceuticals, Inc. (NYSE:BDY) today announced its launch of Veregen(TM) (sinecatechins) Ointment, 15%, indicated for the topical...
FAIRFIELD, N.J., Nov. 26 /PRNewswire-FirstCall/ -- Bradley Pharmaceuticals, Inc. (NYSE:BDY) today announced that its Doak Dermatologics subsidiary has launched ROSULA(R) CLK(TM), a kit combining...
FAIRFIELD, N.J., Nov. 8 /PRNewswire-FirstCall/ -- Bradley Pharmaceuticals, Inc. (NYSE:BDY) announced today that it has filed with the Securities and Exchange Commission its Quarterly Report on...
-- Acquisition will add to the branded dermatologic line as a growth driver for the future MELVILLE, N.Y., Oct. 30 /PRNewswire/ -- Nycomed today announced the entry into a definitive agreement to...
FAIRFIELD, N.J., Oct. 30 /PRNewswire-FirstCall/ -- Bradley Pharmaceuticals, Inc. (NYSE:BDY) announced today that it has entered into a definitive merger agreement with Nycomed US Inc., a...
FAIRFIELD, N.J., Sept. 28 /PRNewswire-FirstCall/ -- Bradley Pharmaceuticals, Inc. (NYSE:BDY) today announced that its Kenwood Therapeutics division will feature Elestrin(TM) (estradiol gel...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales